Revolutionizing Lyme Diagnostics - Episode 341

In this episode of the Gladden Longevity Podcast, Dr. Jeffrey Gladden speaks with Nicole Bell and Jennifer Miller from Galaxy Diagnostics about the challenges and advancements in diagnosing and treating tick-borne illnesses, particularly Lyme disease. They discuss the personal journey that led Nicole to become the CEO of Galaxy Diagnostics, the complexities of the immune response to Lyme, and the innovative diagnostic approaches being developed to improve patient outcomes. The conversation also touches on the implications of co-infections and the future of research in this critical area of health.   For Audience Join the other 20,000+ high-performers getting weekly insights on biological reversal, exponential strategies, and Life Energy optimization→ https://start.gladdenlongevity.com/subscribe If you're ready to measure your 60+ biological ages and build a personalized reversal plan, apply for a discovery call here → https://start.gladdenlongevity.com/apply-now   Use code 'Podcast10' to get 10% OFF on any of our supplements at https://gladdenlongevityshop.com/!      Takeaways ·       Nicole Bell's personal experience with tick-borne illness led her to Galaxy Diagnostics. ·       Lyme disease can be misdiagnosed, leading to severe consequences. ·       The immune response to Lyme is complex and can lead to chronic inflammation. ·       Genetic predispositions can affect how individuals respond to tick-borne pathogens. ·       Innovative diagnostic methods are being developed to improve detection of Lyme and co-infections. ·       Urine samples can be effective for diagnosing Lyme disease. <span style= "font-family: Symbol;